Biotransformation of the Antiretroviral Drug Etravirine: Metabolite Identification, Reaction Phenotyping, and Characterization of Autoinduction of Cytochrome P450-Dependent Metabolism-Reference-Cited by-同舟云学术

Biotransformation of the Antiretroviral Drug Etravirine: Metabolite Identification, Reaction Phenotyping, and Characterization of Autoinduction of Cytochrome P450-Dependent Metabolism

Published:2012-01-23 Issue:4 Volume:40 Page:803-814
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Yanakakis Lindsay J.,Bumpus Namandjé N.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference33 articles.

1. TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1

2. Pharmacokinetics of the raltegravir/maraviroc/etravirine combination

3. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans;de Morais;J Biol Chem,1994

4. CYP2C19 Inhibition: The Impact of Substrate Probe Selection on in Vitro Inhibition Profiles

5. Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized Trial

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review Concerning the Use of Etravirine and Darunavir in Translational Medicine;International Journal of Translational Medicine;2023-10-27

2. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance;Pharmacology & Therapeutics;2023-08

3. Management of a drug–drug interaction between BRAF inhibitors and combined antiretroviral therapy in a HIV-infected patient with craniopharyngioma;AIDS;2023-06-01

4. Interactions of Antiretroviral Drugs with Food, Beverages, Dietary Supplements, and Alcohol: A Systematic Review and Meta-analyses;AIDS and Behavior;2022-11-01

5. Impact of pregnancy on maternal pharmacokinetics of medications;Clinical Pharmacology During Pregnancy;2022